CDKN3 and renal cell carcinoma: Our recent study also demonstrated that the expression of KAP was associated with poorly differentiated human renal cell carcinoma and that the overexpression of KAP in vitro enhanced cell proliferation, resistance to apoptosis and xenograft tumor formation (17).